文献速递腹部骨肌MR

非酒精性脂肪性肝病患者中肝细胞癌与骨骼肌脂肪浸润异质性模式相关

Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease is associated with heterogeneous pattern of fat infiltration in skeletal muscles.
PubMed 文献 · Eur Radiol · 2023-09-02

在72例经组织学证实的非酒精性脂肪性肝病(NAFLD)横断面队列中,其中20例经活检诊断肝细胞癌(HCC),采用MRI质子密度脂肪分数(PDFF)评估第三腰椎水平骨骼肌脂肪浸润。结果显示HCC患者竖脊肌PDFF较无HCC者高70%(9.6±5.5% vs 5.7±3.0%,p<0.001),PDFFES预测HCC的AUC为0.72(95%CI 0.57-0.86,p=0.002),在非酒精性脂肪性肝炎(NASH)患者中AUC为0.79(95%CI 0.63-0.86,p=0.006)。

要点

  • NAFLD患者中,竖脊肌PDFF较高与HCC存在独立关联(AUC=0.72,95%CI 0.57-0.86,p=0.002)。
  • NASH患者中,椎旁肌影像组学异质性特征(如能量、熵)可独立预测HCC,EnergyES的AUC=0.92(95%CI 0.82-1.00,p<0.001)。
  • 肌脂肪变与HCC的关联独立于肝纤维化分期。

核心结论

  • 在NAFLD患者中,尤其是NASH患者,肌脂肪变的程度和异质性与HCC独立相关,且不依赖于肝纤维化分期。

研究设计与样本

  • 横断面队列研究,纳入72例经组织学证实的NAFLD患者(其中38例NASH),20例经活检诊断HCC;采用MRI质子密度脂肪分数(PDFF)评估第三腰椎水平骨骼肌(竖脊肌、腰方肌、腰大肌、斜肌、直肌)的脂肪浸润程度及一阶影像组学特征。

关键影像表现/征象

  • HCC患者竖脊肌PDFF为9.6±5.5%,无HCC者为5.7±3.0%,HCC患者较无HCC者高70%(p<0.001)。
  • NASH患者中,椎旁肌(竖脊肌、腰方肌或腰大肌)的影像组学异质性特征(如能量和熵)是HCC的独立预测因素。

诊断标准与关键数值

  • 竖脊肌PDFF预测HCC的AUC=0.72(95%CI 0.57-0.86,p=0.002),独立于年龄、性别、内脏脂肪面积和肝纤维化分期(均p<0.05)。
  • NASH患者中竖脊肌PDFF预测HCC的AUC=0.79(95%CI 0.63-0.86,p=0.006)。
  • NASH患者中EnergyES识别HCC(n=13)的AUC=0.92(95%CI 0.82-1.00,p<0.001)。

临床应用与阅片要点

  • 在NAFLD患者,尤其是NASH患者中,可关注椎旁肌脂肪浸润的程度及影像组学异质性特征,作为HCC风险的潜在生物标志物。
  • 肌脂肪变与HCC的关联独立于肝纤维化分期,阅片时不应仅依据肝纤维化分期评估HCC风险。

局限性

  • 本文为横断面研究,作者在临床相关性声明中指出数据提示肌脂肪变可作为HCC生物标志物,并为纵向研究奠定基础,尚需进一步纵向研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To evaluate the association between fat infiltration in skeletal muscles (myosteatosis) and hepatocellular carcinoma (HCC) in patients with non-alcoholic fatty liver disease (NAFLD).

METHODS: In a cross-sectional cohort of 72 histologically proven NAFLD patients (n = 38 with non-alcoholic steatohepatitis; NASH), among which 20 had HCC diagnosed on biopsy, we used proton density fat fraction (PDFF) at MRI to evaluate myosteatosis in skeletal muscles (mean fat fraction and first order radiomic-based pattern) at the third lumbar level, namely in erector spinae (ES), quadratus lumborum (QL), psoas, oblique, and rectus muscles.

RESULTS: PDFFES was 70% higher in patients with HCC when compared to those without HCC (9.6 ± 5.5% versus 5.7 ± 3.0%, respectively, p < 0.001). In multivariate logistic regression, PDFFES was a significant predictor of the presence of HCC (AUC = 0.72, 95% CI 0.57-0.86, p = 0.002) independently from age, sex, visceral fat area, and liver fibrosis stage (all p < 0.05). The relationship between PDFFES and HCC was exacerbated in patients with NASH (AUC = 0.79, 95% CI 0.63-0.86, p = 0.006). In patients with NASH, radiomics features of heterogeneity such as energy and entropy in any of the paraspinal muscles (i.e., ES, QL, or psoas) were independent predictors of HCC. EnergyES identified patients with HCC (n = 13) in the NASH population with AUC = 0.92 (95% CI 0.82-1.00, p < 0.001).

CONCLUSION: In patients with NAFLD, and more specifically in those with NASH, the degree and heterogeneity of myosteatosis is independently associated with HCC irrespective of liver fibrosis stage.

CLINICAL RELEVANCE STATEMENT: Our data suggest that myosteatosis could be used as a biomarker of HCC in the ever-expanding NAFLD population and pave the way for further investigation in longitudinal studies.

KEY POINTS: • HCC in patients with non-alcoholic fatty liver disease, and more specifically in those with non-alcoholic steatohepatitis, is independently associated with severe fatty infiltration (myosteatosis) of paravertebral skeletal muscles. • Association between myosteatosis and HCC is independent from liver fibrosis stage. • Histogram-based radiomics features of myosteatosis predicts the risk of HCC in patients with non-alcoholic steatohepatitis.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Nachit M, Dioguardi Burgio M, Abyzov A, et al. Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease is associated with heterogeneous pattern of fat infiltration in skeletal muscles. Eur Radiol. 2023. PMID: 37658893. doi:10.1007/s00330-023-10131-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。